Press Release: BioSkryb : BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb has joined the NIST Genome Editing Consortium to help enable increased confidence in gene edited research and commercial products
Read full article »
BioSkryb is a North Carolina-based company that provides services such as single-cell molecular discovery and analysis for the biotech industry.
Read more